Interpreting the evidence: choosing between randomised and non-randomised studies

This is the first of four articles Evaluations of healthcare interventions can either randomise subjects to comparison groups, or not. In both designs there are potential threats to validity, which can be external (the extent to which they are generalisable to all potential recipients) or internal (whether differences in observed effects can be attributed to differences in the intervention). Randomisation should ensure that comparison groups of sufficient size differ only in their exposure to the intervention concerned. However, some investigators have argued that randomised controlled trials (RCTs) tend to exclude, consciously or otherwise, some types of patient to whom results will subsequently be applied Furthermore, in unblinded trials the outcome of treatment may be influenced by practitioners' and patients' preferences for one or other intervention. Though non-randomised studies are less selective in terms of recruitment, they are subject to selection bias in allocation if treatment is related to initial prognosis. #### Summary points Treatment effects obtained from randomised and non-randomised studies may differ, but one method does not give a consistently greater effect than the other Treatment effects measured in each type of study best approximate when the exclusion criteria are the same and where potential prognostic factors are well understood and controlled for in the non-randomised studies Subjects excluded from randomised controlled trials tend to have a worse prognosis than those included, and this limits generalisability Subjects participating in randomised controlled trials evaluating treatment of existing conditions tend to be less affluent, educated, and healthy than those who do not; the opposite is true for trials of preventive interventions View this table: Threats to validity of evaluative research and possible solutions These issues have led to extensive debate, although empirical evidence is limited. This paper is a brief summary of a more detailed review1 of the impact of these potential threats. The review focused …

[1]  M. Ferri,et al.  Surgical care in octogenarians , 1996, The British journal of surgery.

[2]  G. Mead,et al.  HIGH TECHNOLOGY MEDICAL INTERVENTIONS: WHAT DO OLDER PEOPLE WANT? , 1997, Journal of the American Geriatrics Society.

[3]  L. Balducci,et al.  Recombinant Hemopoietic Growth Factors: Comparative Hemopoietic Response in Younger and Older Subjects , 1992, Journal of the American Geriatrics Society.

[4]  A A Rimm,et al.  Mortality after coronary angioplasty and coronary artery bypass surgery (the national Medicare experience). , 1992, The American journal of cardiology.

[5]  J. Samet,et al.  Temporal and Regional Variability in the Surgical Treatment of Cancer Among Older People , 1996, Journal of the American Geriatrics Society.

[6]  M J Campbell,et al.  Choosing between randomised and non-randomised studies: a systematic review , 1998, BMJ.

[7]  Les M Irwig,et al.  An evidence based approach to individualising treatment , 1995, BMJ.

[8]  M. Whitehouse,et al.  A policy framework for commissioning cancer services , 1995, BMJ.

[9]  M. van Glabbeke,et al.  Age has no impact on acute and late toxicity of curative thoracic radiotherapy. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  P Selby,et al.  Benefits from specialised cancer care , 1996, The Lancet.

[11]  G. Stukenborg,et al.  Comparison of carotid endarterectomy outcomes from randomized controlled trials and Medicare administrative databases. , 1997, Archives of neurology.

[12]  J. McKay,et al.  Effect of random versus nonrandom assignment in a comparison of inpatient and day hospital rehabilitation for male alcoholics. , 1995, Journal of consulting and clinical psychology.

[13]  V. Zagonel,et al.  Age as a risk factor for inadequate treatment. , 1988, JAMA.

[14]  M. Weinrich,et al.  Cancer knowledge among elderly individuals , 1986, Cancer nursing.

[15]  S. Dahrouge,et al.  Oral Etoposide and Carboplatin: Effective Therapy for Elderly Patients with Small Cell Lung Cancer , 1995, American journal of clinical oncology.

[16]  Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation , 1994, The Lancet.

[17]  W. Hazzard,et al.  Integrating Geriatrics into the Subspecialties of Internal Medicine: The Hartford Foundation/American Geriatrics Society/Wake Forest University Bowman Gray School of Medicine Initiative , 1997, Journal of the American Geriatrics Society.

[18]  R. Sainsbury,et al.  Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group. , 1995, British Journal of Cancer.

[19]  K. McPherson,et al.  Are Randomized Controlled Trials Controlled? Patient Preferences and Unblind Trials , 1997, Journal of the Royal Society of Medicine.

[20]  A D Oxman,et al.  The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials , 1998, BMJ.

[21]  S. Monfardini What do we know on variables influencing clinical decision-making in elderly cancer patients? , 1996, European journal of cancer.

[22]  D. Cella,et al.  Age and clinical decision making in oncology patients. , 1994, Journal of the National Cancer Institute.

[23]  P. Carbone,et al.  Palliative medicine in the elderly , 1997, Cancer.

[24]  R B Haynes,et al.  Patient compliance and the conduct and interpretation of therapeutic trials. , 1987, Controlled clinical trials.

[25]  B. Given,et al.  The impact of age, treatment, and symptoms on the physical and mental health of cancer patients , 1994, Cancer.

[26]  S. Lichtman,et al.  Pharmacology of antineoplastic agents in older cancer patients. , 2000, Oncology.

[27]  I. Fentiman,et al.  Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)? , 1997, European journal of cancer.

[28]  J. Hendriks,et al.  Mammographic screening after the age of 65 years: Evidence for a reduction in breast cancer mortality , 1996, International journal of cancer.

[29]  D. Hunninghake,et al.  Recruitment experience in clinical trials: literature summary and annotated bibliography. , 1987, Controlled clinical trials.

[30]  D M Buchner,et al.  Unstable disability and the fluctuations of frailty. , 1997, Age and ageing.

[31]  A. Kinmonth,et al.  Effect of non-attenders on the potential of a primary care programme to reduce cardiovascular risk in the population , 1994, BMJ.

[32]  M Baum,et al.  Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. , 1990, BMJ.

[33]  H. Bartelink,et al.  Age is not a limiting factor for radical radiotherapy in pelvic malignancies. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  D. Torgerson,et al.  Patient Preferences in Randomised Trials: Threat or Opportunity? , 1996, Journal of health services research & policy.

[35]  C. Viscoli,et al.  Developing improved observational methods for evaluating therapeutic effectiveness. , 1990, The American journal of medicine.

[36]  R. Uhlmann,et al.  Quality of life in chronic diseases: perceptions of elderly patients. , 1988, Journal of gerontology.

[37]  I. Holme Cholesterol reduction and its impact on coronary artery disease and total mortality. , 1995, The American journal of cardiology.

[38]  J. Coebergh Significant trends in cancer in the elderly. , 1996, European journal of cancer.

[39]  S. Yusuf,et al.  Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. , 1990, Statistics in medicine.

[40]  J. Avorn,et al.  The exclusion of the elderly and women from clinical trials in acute myocardial infarction. , 1992, JAMA.

[41]  R. Califf,et al.  Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. , 1996, The Journal of thoracic and cardiovascular surgery.

[42]  P. Newcomb,et al.  Cancer treatment and age: patient perspectives. , 1993, Journal of the National Cancer Institute.

[43]  I. Fentiman Are the elderly receiving appropriate treatment for cancer? , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  N. Black Why we need observational studies to evaluate the effectiveness of health care , 1996, BMJ.

[45]  C. Ruggiero,et al.  Results of surgical resection in patients over the age of 70 years with non small-cell lung cancer. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[46]  K McPherson,et al.  The Cochrane Lecture. The best and the enemy of the good: randomised controlled trials, uncertainty, and assessing the role of patient choice in medical decision making. , 1994, Journal of epidemiology and community health.

[47]  W. F. White,et al.  Once weekly irradiation in breast cancer. , 1987, International journal of radiation oncology, biology, physics.

[48]  D. King,et al.  Breast examinations in older women: questionnaire survey of attitudes of patients and doctors , 1997, BMJ.